Mr Panos Gikas Featured

Featured Consultant

Mr Panagiotis Gikas

Mr Gikas has completed his medical school and postgraduate training in London and specialises in primary and revision hip and knee arthroplasty, knee cartilage injuries and the surgical management of primary and metastatic bone cancer.

Mr Gikas’s clinical and research endeavours have centred around hip and knee reconstruction and treatment of bone and soft tissue cancer. His interests include the use of the anterior approach to hip replacement, custom made (bespoke) instruments as well as robotics for knee replacement, use of stem cells and cartilage techniques to address cartilage defects and the management of major bone and soft tissue cancer. He has presented and published widely on various aspects of hip, knee and bone cancer surgery and continues to lead clinical and laboratory research in these fields.

Specialty:
Trauma and orthopaedics, bone and soft tissue sarcomas

Procedures Offered:
Primary total hip replacement (including the use of the anterior muscle sparing approach), primary knee replacement, revision hip and knee replacement, repair of articular cartilage defects of the knee, knee arthroscopy, massive endoprosthetic replacement for treatment of primary and metastatic bone cancer, surgical management of soft tissue cancer

Clinical Interests:
Arthroplasty, Orthopaedic Oncology, Cartilage Regeneration

Research Interests:
Techniques that allow optimisation of hip and knee replacements either by minimising damage to muscle or by using instruments/implants that are custom made to take into account the individual patient anatomy, new techniques to optimise outcome after bone resection for treatment of primary/secondary cancer using massive prosthetic implants, Raman spectroscopy for non-invasive diagnosis of bone disease

Published Papers:
Towards the in vivo prediction of fragility fractures with Raman spectroscopy.
Buckley K, Kerns JG, Vinton J, Gikas PD, Smith C, Parker AW, Matousek P, Goodship AE.
J Raman Spectrosc. 2015 Jul;46(7):610-618
Hydroxyapatite-coated collars reduce radiolucent line progression in cemented distal femoral bone tumor implants.
Coathup MJ, Sanghrajka A, Aston WJ, Gikas PD, Pollock RC, Cannon SR, Skinner JA, Briggs TW, Blunn GW.
Clin Orthop Relat Res. 2015 Apr;473(4):1505-14. doi: 10.1007/s11999-014-4116-6
Evidence from Raman spectroscopy of a putative link between inherent bone matrix chemistry and degenerative joint disease.
Kerns JG, Gikas PD, Buckley K, Shepperd A, Birch HL, McCarthy I, Miles J, Briggs TW, Keen R, Parker AW, Matousek P, Goodship AE.
Arthritis Rheumatol. 2014 May;66(5):1237-46. doi: 10.1002/art.38360.
Current strategies for knee cartilage repair.
Kalson NS, Gikas PD, Briggs TW.
Int J Clin Pract. 2010 Sep;64(10):1444-52. doi: 10.1111/j.1742-1241.2010.02420.x. Review
Repair of osteochondral defects in joints--how to achieve success.
Bentley G, Bhamra JS, Gikas PD, Skinner JA, Carrington R, Briggs TW. Injury. 2013 Jan;44 Suppl 1:S3-10. doi: 10.1016/S0020-1383(13)70003-2. Review.
Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway.
Presneau N, Shalaby A, Idowu B, Gikas P, Cannon SR, Gout I, Diss T, Tirabosco R, Flanagan AM.

Mr Panagiotis Gikas, Consultant Orthopaedic Surgeon is available for consultations at the Royal National Orthopaedic Hospital


Find a Consultant

Contact Us

Call: 020 8909 5114
Overseas: +44 20 8909 5114
Email: email us

Our Private Patient Booking Office
is open
9am-5pm, Monday to Friday.

The RNOH Charity

RNOH Appeal Logo